Ezygene Pty. Ltd.

Status: Registered
Australian Company Number: 147210866
Australian Business Number: 18147210866
Registration date: November 5, 2010
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Ezygene Pty Ltd is a limited by shares Australian proprietary company. Located at ACT 2611 since 2014-08-06 the company is, as the updated on 2014-09-26 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2010-11-05. Known company numbers for Ezygene Pty Ltd are as follows: ACN - 147210866, Australian Business Number - 18147210866. This Australian proprietary company was previously located in ACT 2611 (from 2013-03-18 to 2014-08-06), ACT 2611 (from 2013-03-12 to 2013-03-18), ACT 2611 (from 2012-12-20 to 2013-03-12).

Details for ABN 18147210866

Type: Australian Private Company

ABN Status

Status From To
Active November 5, 2010 current

Main Name

Name From To
Ezygene Pty. Ltd. November 5, 2010 current

Main Location

Location From To
ACT 2611 August 6, 2014 current
ACT 2611 March 18, 2013 August 6, 2014
ACT 2611 March 12, 2013 March 18, 2013
ACT 2611 December 20, 2012 March 12, 2013

Goods & Services Tax (GST)

Status From To
Registered November 5, 2010 current

Advertisements

Company Patents

Patent Application Number: 2010330688

General information:

Application date: June 1, 2012
Patent status: Filed

The specification prior to acceptance and where the application has not lapsed

Patent type: NPE
Primary IPC mark: C12Q 1/68
WIPO Application Number: WO2011/069200
Original WIPO Application Number: WO11/69200
PCT Application Number: PCT/AU2010/001659
Original PCT Application Number: PCT/AU10/01659

International Patent Classification:

IPC Mark: C07H 21/00
Version date of the IPC Classification record: January 1, 2006
Section code: C - chemistrymetallurgy
Class code: 7 - organic chemistry
Subclass code: H - sugars; derivatives thereof; nucleosides; nucleotides; nucleic acids (derivatives of aldonic or saccharic acids c07c, c07d; aldonic acids, saccharic acids c07c0059105000, c07c0059285000; cyanohydrins c07c0255160000; glycals c07d; compounds of unknown constitution c07g; polysaccharides, derivatives thereof c08b; dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification c12n0015000000; sugar industry c13)
Main group code: 21 - compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Mark type: Later (ie Secondary)
Classification level: Advanced
Classification code: Inventive
IPC Classification assigned/Application publish date: June 16, 2011
Classification type code: Original
Classification source code: Human

IP Australia process information:

Source code: PAMS
Patent classification type: Standard
Examination request filing date: April 11, 2013
Requested examination type: Request Full Examination
Examination status: Under Examination
First report issue date: November 1, 2014
Examination section: A5 MPEC
Expiry date: December 9, 2030
Earliest priority date: December 9, 2009
WIPO publication date: June 16, 2011
Effective patent date: December 9, 2010
Continue renew fee paid date: November 7, 2014
Patent in force to: December 9, 2015

Find company

ACT 2611 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.